NM_005609.4:c.1366G>A
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PM1PP2PP3_StrongPP5_Very_Strong
The NM_005609.4(PYGM):c.1366G>A(p.Val456Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000687 in 1,600,282 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. V456V) has been classified as Likely benign.
Frequency
Consequence
NM_005609.4 missense
Scores
Clinical Significance
Conservation
Publications
- glycogen storage disease VInheritance: AR, AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PYGM | ENST00000164139.4 | c.1366G>A | p.Val456Met | missense_variant | Exon 11 of 20 | 1 | NM_005609.4 | ENSP00000164139.3 | ||
| PYGM | ENST00000377432.7 | c.1102G>A | p.Val368Met | missense_variant | Exon 9 of 18 | 2 | ENSP00000366650.3 | |||
| PYGM | ENST00000460413.1 | n.*115G>A | downstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152150Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000181 AC: 4AN: 221462 AF XY: 0.0000165 show subpopulations
GnomAD4 exome AF: 0.00000483 AC: 7AN: 1448132Hom.: 0 Cov.: 45 AF XY: 0.00000556 AC XY: 4AN XY: 719880 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152150Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74324 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Glycogen storage disease, type V Pathogenic:5
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 456 of the PYGM protein (p.Val456Met). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with glycogen storage disease, aka polyglucosan body myopathy (PMID: 14568816, 17324573, 17876739, 22250184, 29143597). ClinVar contains an entry for this variant (Variation ID: 95290). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PYGM protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic.
The variant is observed at an extremely low frequency in the gnomAD v4.1.0 dataset (total allele frequency: <0.001%). Predicted Consequence/Location: Missense variant. The majority of the known disease-causing variants of this gene are variants expected to result in premature termination of the protein. In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.92 (>=0.6, sensitivity 0.68 and specificity 0.92); 3Cnet: 0.96 (>=0.6, sensitivity 0.72 and precision 0.9)]. The same nucleotide change resulting in the same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000095290 /PMID: 14568816). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline.
not provided Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at